Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN115872894B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115872894B reveals a safer copper-catalyzed route for contrast agent intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.